BIO and CSBA Letter to Congress to Support One Health and Advance Animal Biotech
June 2, 2020
The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation directing the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop a Memorandum of Understanding (MOU) to streamline the regulatory oversight of animal biotechnology.
Elevating and prioritizing the relationship of living things through One Health strategies and modernizing America’s animal biotechnology regulatory approach are two policies Congress must address in any future COVID-19 legislation. Doing so will ensure we are ready for the next potential animal to human disease outbreak.
On behalf of the broad and diverse stakeholders in American Agriculture we represent, we urge you to work with your colleagues to expeditiously confirm Doug McKalip as Chief Agricultural Negotiator at the Office of the U.S. Trade…
We write to express our support for the nomination of Oregon Department of Agriculture Director Alexis Taylor to serve as the U.S. Department of Agriculture’s Under Secretary for Trade and Foreign Agricultural Affairs. U.S. agricultural producers…
The Biotechnology Innovation Organization (BIO) is pleased to offer comments in response to the Office of Science and Technology Policy (OSTP) request for information on sustainable chemistry. Specifically, we seek to inform the development of a…
The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation directing the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop a Memorandum of Understanding (MOU) to streamline the regulatory oversight of animal biotechnology.
Elevating and prioritizing the relationship of living things through One Health strategies and modernizing America’s animal biotechnology regulatory approach are two policies Congress must address in any future COVID-19 legislation. Doing so will ensure we are ready for the next potential animal to human disease outbreak.